Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.

Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.
复制标题

血清淀粉样蛋白 A 增强分泌型非胰腺磷脂酶 A2 的活性。

DOI:
10.1042/bj3090461
复制
发表时间:
1995
期刊:
The Biochemical journal
影响因子:
--
通讯作者:
Vadas,P
Vadas,P
中科院分区:
--
文献类型:
--
作者:
Pruzanski,W;deBeer,FC;deBeer,MC;Stefanski,E;Vadas,P

文献摘要

被引文献

相似文献

急性时相蛋白血清淀粉样蛋白A蛋白(SAA)和分泌型磷脂酶A2(sPLA 2)在炎症条件下同时表达。SAA与高密度脂蛋白(HDL)相关,改变其理化组成。我们发现,纯化的急性期SAA,但不是组成型的形式,显着增强了以剂量相关的方式与磷脂酰胆碱/溶血磷脂酰胆碱或磷脂酰乙醇胺/溶血磷脂酰乙醇胺脂质体底物的sPLA 2的脂解活性。发现正常HDL以剂量依赖性方式降低sPLA 2活性,但当检测含有27%SAA的急性期HDL时,其增强sPLA 2活性。免疫纯化的抗SAA单特异性抗体完全取消SAA和急性期HDL的增强活性。鉴于HDL在脂蛋白代谢中的中心作用,HDL、SAA和sPLA 2之间的相互作用可能是急性期脂蛋白代谢中检测到的变化的原因。
The acute-phase proteins serum amyloid A protein (SAA) and secretory phospholipase A2 (sPLA2) are simultaneously expressed during inflammatory conditions. SAA associates with high-density lipoprotein (HDL) altering its physicochemical composition. We found that purified acute-phase SAA, but not the constitutive form, markedly enhances the lipolytic activity of sPLA2 in a dose-related manner with phosphatidylcholine/lysophosphatidylcholine or phosphatidylethanolamine/lysophosphatidylethanolamine liposomal substrates. Normal HDL was found to reduce activity of sPLA2 in a dose-dependent manner, but when acute-phase HDL containing 27% SAA was tested, it enhanced sPLA2 activity. Immunopurified monospecific antibodies against SAA completely abolished the enhancing activity of SAA and acute-phase HDL. Given the central role of HDL in lipoprotein metabolism, the interaction between HDL, SAA and sPLA2 may account for changes detected in lipoprotein metabolism during the acute phase.